Economic burden of acute coronary syndrome from payer perspective: In a health system following the Beveridge Model.

IF 3.7 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Layla Abdullah Mahdi, Ali Azeez Al-Jumaili, Cole G Chapman
{"title":"Economic burden of acute coronary syndrome from payer perspective: In a health system following the Beveridge Model.","authors":"Layla Abdullah Mahdi, Ali Azeez Al-Jumaili, Cole G Chapman","doi":"10.1016/j.sapharm.2025.02.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cost of illness (COI) studies provide crucial data to policymakers for prioritizing resource allocation, particularly in Iraq that lacks such studies. The objective of this COI study was to measure the direct medical costs for acute coronary syndrome (ACS) during hospitalization from the payer perspective.</p><p><strong>Methods: </strong>This multi-source hospital-based study collected data from patient medical records, healthcare providers, and hospital administration from December 2023 through January 2024. This study was conducted in a leading public cardiac hospital in Iraq, which serves a diverse patient population from across the country. The direct medical costs of ACS treatment were calculated from the payer's point of view (the Ministry of Health (MOH)) for patients admitted to the public department and from the patient's point of view for those admitted to the private department.</p><p><strong>Results: </strong>The study included 70 patients; 50 in the public department and 20 in the private department. The average cost of ACS treatment during hospitalization for a single patient in the public department was Iraqi Dinar (IQD) 1,101,390 ($725). The coronary angiography/angioplasty (CAA) procedure was the largest contributor to spending, accounting for 72.12 % of total expenditures. The patients who were admitted to the private department paid IQD 864,375 ($569) per patient, on average.</p><p><strong>Conclusion: </strong>This study developed a pragmatic approach to calculate cost-of-illness for health systems following the Beveridge Health Model and do not have specific fees for each service. The Iraqi MOH covers all the expenses in the public department within the public hospitals. Although the patients pay fees for ACS treatment in the private department, the MOH may provide subsidized prices to reduce the actual costs.This study opens the door to study the cost of illness for other diseases in the future and informs the payers about the required budget allocation. The study methods are potentially transferable to any country utilizing the Beveridge Model for healthcare delivery.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.sapharm.2025.02.003","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cost of illness (COI) studies provide crucial data to policymakers for prioritizing resource allocation, particularly in Iraq that lacks such studies. The objective of this COI study was to measure the direct medical costs for acute coronary syndrome (ACS) during hospitalization from the payer perspective.

Methods: This multi-source hospital-based study collected data from patient medical records, healthcare providers, and hospital administration from December 2023 through January 2024. This study was conducted in a leading public cardiac hospital in Iraq, which serves a diverse patient population from across the country. The direct medical costs of ACS treatment were calculated from the payer's point of view (the Ministry of Health (MOH)) for patients admitted to the public department and from the patient's point of view for those admitted to the private department.

Results: The study included 70 patients; 50 in the public department and 20 in the private department. The average cost of ACS treatment during hospitalization for a single patient in the public department was Iraqi Dinar (IQD) 1,101,390 ($725). The coronary angiography/angioplasty (CAA) procedure was the largest contributor to spending, accounting for 72.12 % of total expenditures. The patients who were admitted to the private department paid IQD 864,375 ($569) per patient, on average.

Conclusion: This study developed a pragmatic approach to calculate cost-of-illness for health systems following the Beveridge Health Model and do not have specific fees for each service. The Iraqi MOH covers all the expenses in the public department within the public hospitals. Although the patients pay fees for ACS treatment in the private department, the MOH may provide subsidized prices to reduce the actual costs.This study opens the door to study the cost of illness for other diseases in the future and informs the payers about the required budget allocation. The study methods are potentially transferable to any country utilizing the Beveridge Model for healthcare delivery.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Research in Social & Administrative Pharmacy
Research in Social & Administrative Pharmacy PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
7.20
自引率
10.30%
发文量
225
审稿时长
47 days
期刊介绍: Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信